ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2013

Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease.

Liang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.